Who makes Atropine challenge?

Atropine challenge is developed by Emory University.

What development phase is Atropine challenge in?

Atropine challenge is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Atropine challenge

Emory University · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Atropine challenge
Sponsor	Emory University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comprehensive Esophageal Diagnostics Study (PHASE4)
AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair (NA)
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly (PHASE4)
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes (PHASE4)
Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil (PHASE4)
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Atropine challenge CI brief — competitive landscape report
Atropine challenge updates RSS · CI watch RSS
Emory University portfolio CI